Tata Elxsi has entered into a strategic partnership with the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) to accelerate healthcare innovation by combining medical research, clinical expertise and advanced engineering, as per the exchange filings.
The collaboration, formalised through a Memorandum of Understanding (MoU), aims to develop next-generation healthcare technologies for India and global markets.
The partnership combines SCTIMST's capabilities in cardiovascular sciences, neurosciences, biotechnology and clinical sciences with Tata Elxsi's expertise in product engineering, design, artificial intelligence and digital technologies.
The MoU was signed at SCTIMST, Thiruvananthapuram, in the presence of Dr. Sanjay Behari, Director, SCTIMST, Manoj Raghavan, CEO & Managing Director, Tata Elxsi, and senior leaders from both organisations.
The organisations will collaborate across diagnostics, medical imaging, digital health, biomedical engineering, medical devices and other healthcare technologies.
These solutions are intended to address opportunities in both domestic and international markets.
The partnership establishes an integrated environment that brings together clinicians, specialist researchers, advanced laboratories, prototyping infrastructure, and product engineering capabilities.
This approach is designed to help MedTech companies develop, validate, and scale products more efficiently, while strengthening capabilities in biocompatibility, toxicology, and related fields.
The MoU provides a framework for joint research, academic engagement, technology development initiatives, and intellectual property creation through project-specific collaborations.
Initial efforts will focus on identifying high potential opportunities for collaborative development.
Read More: Infosys Share Price in Focus;Company Faces €175,000 Penalty from French Authority!
As of 27 July 2026, at 3:30 PM, Tata Elxsi Ltd share price closed at ₹3,554.50 per share, reflecting a surge of 0.46% from the previous trading session.
The Tata Elxsi-SCTIMST partnership establishes a collaborative framework for research, engineering and healthcare technology development, covering multiple MedTech segments and supporting innovation for India and global markets.
Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jul 27, 2026, 5:10 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
